Tumorigenesis in mice carrying a truncating Brca1 mutation

AUTOR(ES)

Ludwig, Thomas

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

We generated mouse mutants carrying in the Brca1 locus a modification (Brca1tr) that eliminates the C-terminal half of the protein product and obtained results indicating that, depending on genetic background, the missing BRCT and/or other domains are dispensable for survival, but essential for tumor suppression. Most of the apparently hypomorphic Brca1tr/tr mutants developed various tumors. Lymphomas were detected at all ages, whereas sarcomas and carcinomas, including breast cancer, appeared after a long latency. The mammary tumors showed striking variability in histopathological patterns suggesting stochastic engagement of tumorigenic pathways in their progression, to which the Brca1tr/tr mutation was apparently a late participant.

Documentos Relacionados

• Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1
• BRCA1 transcriptionally regulates genes involved in breast tumorigenesis
• Collaboration of Brca1 and Chk2 in tumorigenesis
• Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
• Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast